Welcome, Guest. Please login or register.
November 14, 2018, 02:14:55 am

Login with username, password and session length


Members
  • Total Members: 33696
  • Latest: RIGuy80
Stats
  • Total Posts: 737704
  • Total Topics: 61108
  • Online Today: 246
  • Online Ever: 1421
  • (August 13, 2016, 05:18:44 am)
Users Online
Users: 2
Guests: 196
Total: 198

Welcome


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Immunotherapy Shows Promise for HIV-Related Kaposi Sarcoma  (Read 400 times)

0 Members and 1 Guest are viewing this topic.

Offline JimDublin

  • Administrator
  • Member
  • Posts: 9,936
  • Twitter @JimAllenDublin
    • HIV Lessons
Immunotherapy Shows Promise for HIV-Related Kaposi Sarcoma
« on: September 12, 2018, 02:07:00 pm »
Very small sample size, still promising results for further research

Jim


Full write-up: https://www.poz.com/article/immunotherapy-shows-promise-hivrelated-kaposi-sarcoma

In short:
Immunotherapy Shows Promise for HIV-Related Kaposi Sarcoma
Six out of nine patients experienced cancer remission with Opdivo or Keytruda.

Treatment with immune checkpoint inhibitors led to complete or partial tumor shrinkage in two thirds of HIV-positive people with Kaposi sarcoma, and none of the treated patients experienced disease progression, according to a recent report in Cancer Immunology Research, a journal published by the American Association for Cancer Research (AACR).

“Based on these results, we think that PD-1 checkpoint blockade may present a promising, novel therapeutic option for HIV-associated Kaposi sarcoma with high efficacy and low toxicity,” Natalie Galanina, MD, of Moores Cancer Center at the University of California San Diego said in an AACR press release.

Once frequently seen among people with AIDS, Kaposi sarcoma (KS) decreased dramatically after the advent of effective antiretroviral treatment as fewer HIV-positive people developed advanced immune suppression with very low CD4 T-cell counts. Nonetheless, KS remains the most common AIDS-defining cancer, even as rates of some non-AIDS-related cancers are rising as people with HIV live longer.
HIV 101 - Everything you need to know
HIV 101
Transmission and Risks:
HIV Transmission and Risks
Read more about Testing here:
HIV Testing
Read about Treatment-as-Prevention (TasP) here:
HIV TasP
You can read about HIV prevention here:
HIV prevention
Read about PEP and PrEP here
PEP and PrEP

 


Terms of Membership for these forums
 

© 2018 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.